Two Cleveland Clinic researchers have been awarded multi-year, multi-million dollar federal grants that support exceptional scientists with a track record of achievement.
Bruce Trapp, Ph.D., a specialist in multiple sclerosis (MS) and myelin biology, and Jaroslaw Maciejewski, M.D., Ph.D., an expert in blood and bone diseases, have each received an Outstanding Investigator Award from the National Institutes of Health (NIH).
The awards are designed to provide long-term support and flexibility to scientists whose work holds out promise for achieving medical breakthroughs, allowing them to focus on research instead of funding.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Cleveland Clinic now has three researchers named outstanding investigators since the NIH introduced the new award strategy in 2015.
Jeremy Rich, M.D., researcher in the Department of Stem Cell Biology & Regenerative Medicine at the Lerner Research Institute, was the first Cleveland Clinic researcher to receive an Outstanding Investigator Award – $6.7 million in 2015.
trapp, bruce
Bruce Trapp, Ph.D.
Trapp, chair of the Department of Neurosciences at the Lerner Research Institute, becomes the first Cleveland Clinic researcher to be named an Outstanding Investigator by the National Institute of Neurological Disorders and Stroke of the NIH. He will receive nearly $7 million over the next eight years to examine the biology of MS and to seek treatments that could slow or reverse the disease.
Dr. Maciejewski, chair of the Department of Translational Hematology and Oncology Research at Cleveland Clinic, will receive more than $5.5 million over the next seven years from the National Heart, Lung and Blood Institute of the NIH. The award will support his work translating scientific advances in bone marrow failure syndromes into improved patient care.
maciejewski, jaroslaw - Copy
Jaroslaw Maciejewski, M.D., Ph.D.
Serpil C. Erzurum, M.D., chair of the Lerner Research Institute, said the grants will help high-achieving researchers find better treatments for people with complex diseases.
“These awards not only honor the remarkable work of these outstanding researchers, but will be a tremendous help in advancing discoveries that will ultimately benefit patients,” she said.
Trapp’s lab produced seminal work in the understanding of MS, a disease of the central nervous system in which the body’s immune system attacks healthy tissue. With MS, the immune system targets myelin, the protective fatty coating that wraps around nerve fibers. By destroying nerve connections, MS can lead to unpredictable fatigue, muscle weakness, difficulty with mobility and even paralysis in later stages.
